Literature DB >> 12948368

Clinical and laboratory presentation of EBV positive infectious mononucleosis in young adults.

I Grotto1, D Mimouni, M Huerta, M Mimouni, D Cohen, G Robin, S Pitlik, M S Green.   

Abstract

Clinical descriptions of Epstein-Barr virus (EBV) positive infectious mononucleosis (IM) are rare and their results are inconsistent. Over a 4-year period, we prospectively studied 590 young adults with clinically suspected IM, all of whom were tested for the presence of EBV IgM antibodies. We investigated the demographical, clinical and laboratory features of subjects with positive EBV IgM serology and heterophile antibodies. Contrary to previous studies, we found a seasonal disease pattern with a peak incidence during summer months, and a lower-than-expected prevalence of lymphadenopathy (88.9%), leucocytosis (46.2%), atypical lymphocytosis (89.2%) and elevated liver enzymes (57.9%). The prevalence of hyperbilirubinemia was relatively high (14.9%). The classic triad of fever, sore throat and lymph-adenopathy had relatively low sensitivity (68.2%) and specificity (41.9%) for EBV infection. Our study provides a complete and updated description of the clinical and laboratory presentation of laboratory confirmed IM, which is important for both clinicians and epidemiologists.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12948368      PMCID: PMC2870009          DOI: 10.1017/s0950268803008550

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  13 in total

1.  Real-time Epstein-Barr virus PCR for the diagnosis of primary EBV infections and EBV reactivation.

Authors:  Rianne Luderer; Marieke Kok; Hubert G M Niesters; Rob Schuurman; Okke de Weerdt; Steven F T Thijsen
Journal:  Mol Diagn       Date:  2005

2.  Secular and seasonal trends of infectious mononucleosis among young adults in Israel: 1978-2009.

Authors:  H Levine; D Mimouni; I Grotto; A Zahavi; O Ankol; M Huerta-Hartal
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-08-03       Impact factor: 3.267

Review 3.  Progress and problems in understanding and managing primary Epstein-Barr virus infections.

Authors:  Oludare A Odumade; Kristin A Hogquist; Henry H Balfour
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

4.  Diagnosis of infectious mononucleosis by combined detection of atypical lymphocytes and transaminase.

Authors:  Lihua Hu; Juhong Yang; Tianpen Cui; Hui Xing; Pengcheng Cai
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

5.  Epidemiologic and clinical characteristics of infectious mononucleosis associated with Epstein-Barr virus infection in children in Beijing, China.

Authors:  Li-Wei Gao; Zheng-De Xie; Ya-Yi Liu; Yan Wang; Kun-Ling Shen
Journal:  World J Pediatr       Date:  2010-12-30       Impact factor: 2.764

6.  Increasing incidence of severe Epstein-Barr virus-related infectious mononucleosis: surveillance study.

Authors:  Pierre Tattevin; Yves Le Tulzo; Sophie Minjolle; Arnaud Person; Jean Marc Chapplain; Cedric Arvieux; Remi Thomas; Christian Michelet
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

7.  Epidemiological characteristics and disease burden of infectious mononucleosis in hospitalized children in China: A nationwide retrospective study.

Authors:  Mengjia Liu; Xinyu Wang; Linlin Zhang; Guoshuang Feng; Yueping Zeng; Ran Wang; Zhengde Xie
Journal:  Virol Sin       Date:  2022-07-12       Impact factor: 6.947

8.  Clinical and laboratory characteristics of infectious mononucleosis by Epstein-Barr virus in Mexican children.

Authors:  Napoleón González Saldaña; Victor Antonio Monroy Colín; Georgina Piña Ruiz; Hugo Juárez Olguín
Journal:  BMC Res Notes       Date:  2012-07-20

9.  Clinical features of Epstein-Barr virus-associated infectious mononucleosis in hospitalized Korean children.

Authors:  Keun Hyung Son; Mee Yong Shin
Journal:  Korean J Pediatr       Date:  2011-10-31

Review 10.  Herpes Simplex Virus 1 Infection of Neuronal and Non-Neuronal Cells Elicits Specific Innate Immune Responses and Immune Evasion Mechanisms.

Authors:  Amanda L Verzosa; Lea A McGeever; Shun-Je Bhark; Tracie Delgado; Nicole Salazar; Erica L Sanchez
Journal:  Front Immunol       Date:  2021-05-31       Impact factor: 8.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.